ARTICLE | Clinical News
PA401 regulatory update
September 15, 2008 7:00 AM UTC
FDA granted Orphan Drug designation for ProtAffin's PA401 to prevent delayed graft function (DGF) after solid organ transplant. The recombinant human CXCL8 mutant, which displaces chemokine IL-8 from...